CCR5 inhibition in critical COVID-19 patients decreases inflammatory cytokines, increases CD8 T-cells, and decreases SARS-CoV2 RNA in plasma by day 14
到第 14 天，重症 COVID-19 患者中 CCR5 抑制可减少炎症细胞因子、增加 CD8 T 细胞并降低血浆中的 SARS-CoV2 RNA
期刊:International Journal of Infectious Diseases
影响因子:4.8
doi:10.1016/j.ijid.2020.10.101
Bruce K Patterson, Harish Seethamraju, Kush Dhody, Michael J Corley, Kazem Kazempour, Jay Lalezari, Alina P S Pang, Christopher Sugai, Eisa Mahyari, Edgar B Francisco, Amruta Pise, Hallison Rodrigues, Helen L Wu, Gabriela M Webb, Byung S Park, Scott Kelly, Nader Pourhassan, Alina Lelic, Lama Kdouh,
